Harriet E. Gee

Sydney, NSW 2145, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Atovaquone Targets Mitochondrial Metabolism and Enhances Radiosensitivity of Diffuse Intrinsic Pontine Glioma.

Atovaquone Targets Mitochondrial Metabolism and Enhances Radiosensitivity of Diffuse Intrinsic Pontine Glioma.

Journal: Cancers

Published: February 19, 2026

Single- Versus Multi-Fraction Stereotactic Body Radiotherapy for Primary Lung Cancer and Pulmonary Oligometastases: A Systematic Review and Meta-Analyses.

Single- Versus Multi-Fraction Stereotactic Body Radiotherapy for Primary Lung Cancer and Pulmonary Oligometastases: A Systematic Review and Meta-Analyses.

Journal: JTO clinical and research reports

Published: October 19, 2025

Advances and Future Perspectives for the Management of Non-Small Cell Lung Cancer in Australia: A Narrative Review.

Advances and Future Perspectives for the Management of Non-Small Cell Lung Cancer in Australia: A Narrative Review.

Journal: Asia-Pacific journal of clinical oncology

Published: August 25, 2025

DNA-repair-driven cell death compels us to rethink cancer therapies.

DNA-repair-driven cell death compels us to rethink cancer therapies.

Journal: Nature reviews. Molecular cell biology

Published: August 02, 2025

Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.

Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.

Journal: BMJ open

Published: July 07, 2025

Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial.

Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial.

Journal: International journal of radiation oncology, biology, physics

Published: July 01, 2025

Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.

Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.

Journal: Cancer & metabolism

Published: February 11, 2025

A Response Letter to Kosaka et al. Regarding Manuscript Titled: "Radiotherapy Improves Survival in Non-Small Cell Lung Cancer Following Oligoprogression on Immunotherapy: A Cohort Study".

A Response Letter to Kosaka et al. Regarding Manuscript Titled: "Radiotherapy Improves Survival in Non-Small Cell Lung Cancer Following Oligoprogression on Immunotherapy: A Cohort Study".

Journal: JTO clinical and research reports

Published: January 29, 2025

Prognostic and predictive roles of circulating microRNAs as biomarkers in head and neck cancer patients in the Northern Territory, Australia undergoing chemoradiotherapy-a pilot prospective cohort study.

Prognostic and predictive roles of circulating microRNAs as biomarkers in head and neck cancer patients in the Northern Territory, Australia undergoing chemoradiotherapy-a pilot prospective cohort study.

Journal: Translational cancer research

Published: November 24, 2024

Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma.

Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma.

Journal: Neuro-oncology

Published: November 22, 2024

Immune Checkpoint Inhibitors +/- Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta-Analysis.

Immune Checkpoint Inhibitors +/- Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta-Analysis.

Journal: Thoracic cancer

Published: September 23, 2024

Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy.

Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy.

Journal: Cancers

Published: April 29, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026